Clinical Trial Update: Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing hormonal and lipid changes in male subjects after switching from carbamazepine to lacosamide for epilepsy; the study was terminated, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial Epilepsy

Drugs mentioned

• Carbamazepine (Carbamazepine)
• Lacosamide (Lacosamide)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy, Partial | Phase 3 | Status: TERMINATED | Results posted: 2014-11-26